Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heart failure in elderly patients.

Martin Spiecker1

  • 1Department of Cardiology, Marien-Hospital Marl, Hervester Strasse 57, 45768 Marl, Germany. martin.spiecker@ruhr-uni-bochum.de

Experimental Gerontology
|April 20, 2006
PubMed
Summary

Elderly heart failure patients often experience diastolic dysfunction, particularly women. While treatments for systolic heart failure are similar to younger patients, specific therapies for diastolic heart failure (heart failure with normal ejection fraction) require more research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantum coherent manipulation and readout of superconducting vortex states.

Nature·2026
Same author

Offset Charge Dependence of Measurement-Induced Transitions in Transmons.

Physical review letters·2025
Same author

Granular aluminium as a superconducting material for high-impedance quantum circuits.

Nature materials·2019
Same author

Rapid nonlinear image scanning microscopy.

Nature methods·2017
Same author

The use of paclitaxel coated balloon (PCB) in acute coronary syndrome of small vessel de novo lesions: an analysis of a prospective 'real world' registry.

SpringerPlus·2016
Same author

The CYP2J2 G-50T polymorphism and myocardial infarction in patients with cardiovascular risk profile.

BMC cardiovascular disorders·2008

Area of Science:

  • Cardiology
  • Geriatrics
  • Internal Medicine

Background:

  • Aging leads to structural and functional heart changes, increasing susceptibility to heart failure.
  • Elderly patients exhibit increased sympathetic activity, ventricular remodeling, fibrosis, apoptosis, and vascular stiffening.
  • Diastolic heart failure, or heart failure with normal left ventricular ejection fraction (LVEF), is more prevalent than systolic heart failure in the elderly, especially women.

Purpose of the Study:

  • To review the structural and functional changes contributing to heart failure in the elderly.
  • To discuss the implications of systolic and diastolic heart failure on morbidity and mortality in older adults.
  • To outline current therapeutic strategies for heart failure in elderly patients, considering age-related physiological changes and the need for evidence-based treatments for heart failure with normal LVEF.

Related Experiment Videos

Main Methods:

  • Review of age-related cardiac structural and functional alterations.
  • Analysis of epidemiological data on systolic versus diastolic heart failure in the elderly.
  • Examination of current treatment guidelines and meta-analyses for heart failure in older populations.

Main Results:

  • Elderly patients show a shift towards diastolic heart failure, with increased morbidity and mortality.
  • Systolic heart failure in the elderly carries higher mortality than in younger patients, while diastolic heart failure also increases mortality compared to healthy elderly individuals.
  • Beta-blockers may improve survival in elderly systolic heart failure patients, but evidence for specific therapies in heart failure with normal LVEF remains limited.

Conclusions:

  • Heart failure in the elderly is characterized by significant age-related cardiac changes, leading to a higher prevalence of diastolic dysfunction.
  • Current treatment guidelines for systolic heart failure in the elderly are largely extrapolated from younger populations, with some evidence supporting beta-blocker use.
  • Effective management of heart failure with normal LVEF in the elderly requires further randomized trials to establish optimal therapeutic strategies beyond general measures and blood pressure control.